Ardelyx (ARDX) Stock Is Tumbling On FDA News

Ardelyx ARDX Stock News

Ardelyx Inc (NASDAQ: ARDX) is taking a dive in the market this morning with the stock down more than 70% in the premarket as a result of sobering news from the FDA. Unfortunately, there’s a problem with the company’s recently submitted New Drug Application.  Here’s what’s happening: Stop wasting your time! Start finding winning trades … Read more